These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
229 related items for PubMed ID: 9233765
1. In vivo regulation of single copy and amplified N-myc in human neuroblastoma cells. Lutz W, Schwab M. Oncogene; 1997 Jul 17; 15(3):303-15. PubMed ID: 9233765 [Abstract] [Full Text] [Related]
2. Autoregulation of the human N-myc oncogene is disrupted in amplified but not single-copy neuroblastoma cell lines. Sivak LE, Tai KF, Smith RS, Dillon PA, Brodeur GM, Carroll WL. Oncogene; 1997 Oct 16; 15(16):1937-46. PubMed ID: 9365240 [Abstract] [Full Text] [Related]
3. Cell type-specific expression and negative regulation by retinoic acid of the human N-myc promoter in neuroblastoma cells. Wada RK, Seeger RC, Reynolds CP, Alloggiamento T, Yamashiro JM, Ruland C, Black AC, Rosenblatt JD. Oncogene; 1992 Apr 16; 7(4):711-7. PubMed ID: 1565467 [Abstract] [Full Text] [Related]
4. Transcriptional regulation of the mouse PNRC2 promoter by the nuclear factor Y (NFY) and E2F1. Zhou D, Masri S, Ye JJ, Chen S. Gene; 2005 Nov 21; 361():89-100. PubMed ID: 16181749 [Abstract] [Full Text] [Related]
5. Inhibition of N-myc expression and induction of apoptosis by iron chelation in human neuroblastoma cells. Fan L, Iyer J, Zhu S, Frick KK, Wada RK, Eskenazi AE, Berg PE, Ikegaki N, Kennett RH, Frantz CN. Cancer Res; 2001 Feb 01; 61(3):1073-9. PubMed ID: 11221835 [Abstract] [Full Text] [Related]
6. N-myc regulation of type I insulin-like growth factor receptor in a human neuroblastoma cell line. Chambéry D, Mohseni-Zadeh S, de Gallé B, Babajko S. Cancer Res; 1999 Jun 15; 59(12):2898-902. PubMed ID: 10383152 [Abstract] [Full Text] [Related]
7. Lack of correlation between N-myc and MAX expression in neuroblastoma tumors and in cell lines: implication for N-myc-MAX complex formation. Raschella G, Romeo A, Negroni A, Pucci S, Dominici C, Castello MA, Bevilacqua P, Felsani A, Calabretta B. Cancer Res; 1994 Apr 15; 54(8):2251-5. PubMed ID: 8174135 [Abstract] [Full Text] [Related]
8. Expression of the TAF4b gene is induced by MYC through a non-canonical, but not canonical, E-box which contributes to its specific response to MYC. Teye K, Okamoto K, Tanaka Y, Umata T, Ohnuma M, Moroi M, Kimura H, Tsuneoka M. Int J Oncol; 2008 Dec 15; 33(6):1271-80. PubMed ID: 19020761 [Abstract] [Full Text] [Related]
9. Cell type-specific activity of the N-myc promoter in human neuroblastoma cells is mediated by a downstream silencer. Woodruff KA, Rosenblatt JD, Moore TB, Medzoyan RH, Pai DS, Noland JL, Yamashiro JM, Wada RK. Oncogene; 1995 Apr 06; 10(7):1335-41. PubMed ID: 7731684 [Abstract] [Full Text] [Related]
10. ECA39 is regulated by c-Myc in human and by a Jun/Fos homolog, Gcn4, in yeast. Ben-Yosef T, Yanuka O, Benvenisty N. Oncogene; 1996 Nov 07; 13(9):1859-66. PubMed ID: 8934531 [Abstract] [Full Text] [Related]
11. A novel MASH1 enhancer with N-myc and CREB-binding sites is active in neuroblastoma. Watt F, Watanabe R, Yang W, Agren N, Arvidsson Y, Funa K. Cancer Gene Ther; 2007 Mar 07; 14(3):287-96. PubMed ID: 17124508 [Abstract] [Full Text] [Related]
12. Autoregulation of the N-myc gene is operative in neuroblastoma and involves histone deacetylase 2. Kim MK, Carroll WL. Cancer; 2004 Nov 01; 101(9):2106-15. PubMed ID: 15382088 [Abstract] [Full Text] [Related]
13. Human telomerase reverse transcriptase promoter regulation in normal and malignant human ovarian epithelial cells. Braunstein I, Cohen-Barak O, Shachaf C, Ravel Y, Yalon-Hacohen M, Mills GB, Tzukerman M, Skorecki KL. Cancer Res; 2001 Jul 15; 61(14):5529-36. PubMed ID: 11454703 [Abstract] [Full Text] [Related]
14. Loss of one HuD allele on chromosome #1p selects for amplification of the N-myc proto-oncogene in human neuroblastoma cells. Grandinetti KB, Spengler BA, Biedler JL, Ross RA. Oncogene; 2006 Feb 02; 25(5):706-12. PubMed ID: 16278682 [Abstract] [Full Text] [Related]
15. Sequence of the 5'-flanking region and promoter activity of the human mucin gene MUC5B in different phenotypes of colon cancer cells. Van Seuningen I, Perrais M, Pigny P, Porchet N, Aubert JP. Biochem J; 2000 Jun 15; 348 Pt 3(Pt 3):675-86. PubMed ID: 10840001 [Abstract] [Full Text] [Related]
16. Opposite transcriptional activity between the wild type c-myc gene coding for c-Myc1 and c-Myc2 proteins and c-Myc1 and c-Myc2 separately. Batsché E, Crémisi C. Oncogene; 1999 Oct 07; 18(41):5662-71. PubMed ID: 10523846 [Abstract] [Full Text] [Related]
17. The mouse chemerin receptor gene, mcmklr1, utilizes alternative promoters for transcription and is regulated by all-trans retinoic acid. Mårtensson UE, Bristulf J, Owman C, Olde B. Gene; 2005 Apr 25; 350(1):65-77. PubMed ID: 15792532 [Abstract] [Full Text] [Related]
18. Autorepression of c-myc requires both initiator and E2F-binding site elements and cooperation with the p107 gene product. Luo Q, Li J, Cenkci B, Kretzner L. Oncogene; 2004 Feb 05; 23(5):1088-97. PubMed ID: 14716294 [Abstract] [Full Text] [Related]
19. Fli-1b is generated by usage of differential splicing and alternative promoter. Dhulipala PD, Lee L, Rao VN, Reddy ES. Oncogene; 1998 Sep 03; 17(9):1149-57. PubMed ID: 9764825 [Abstract] [Full Text] [Related]
20. The GATA-1 and Spi-1 transcriptional factors bind to a GATA/EBS dual element in the Fli-1 exon 1. Barbeau B, Barat C, Bergeron D, Rassart E. Oncogene; 1999 Sep 30; 18(40):5535-45. PubMed ID: 10523830 [Abstract] [Full Text] [Related] Page: [Next] [New Search]